S.1801 Proposes “Innovation Incentive Fund for New and More Effective Treatments for Bacterial Infections.” Proposal delinks incentives from prices.

Posted on 15 July 201915 July 2019 by James Love

On June 12, 2019, 15 members of the U.S. Senate introduced S.1801 (116th Congress), a bill to make medicines more affordable. Among the provisions of the bill, which also include a study of delinkage of R&D financing from pricing, is a Innovation Incentive Fund for New and More Effective Treatments for Bacterial Infections. Section 301 Read more about S.1801 Proposes “Innovation Incentive Fund for New and More Effective Treatments for Bacterial Infections.” Proposal delinks incentives from prices.[…]

Franken and Schakowsky Drug Pricing Bill Contains Prize Fund for Antibiotics, Delinkage Study

Posted on 14 April 201714 April 2017 by delinkageadmin

Senator Al Franken, D-Minn., and Representative Jan Schakowsky, D-Ill., along with various high-ranking Democrats in the House and Senate, introduced the Improving Access To Affordable Prescription Drugs Act (S. 771 and H.R. 1776) on March 29, 2017. The bill contains a provision that would create a prize fund for antibiotics. The prize fund would initially Read more about Franken and Schakowsky Drug Pricing Bill Contains Prize Fund for Antibiotics, Delinkage Study[…]

Sen. Sanders Introduces Medical Innovation Prize Fund Act

Posted on 2 March 201724 April 2017 by delinkageadmin

On March 2, 2017, Senator Bernie Sanders, I-Vt., introduced the Medical Innovation Prize Fund Act (S. 495), which would create an over $100 billion prize fund (set at 0.55-percent of the United States GDP) to reward medical innovation in lieu of the grant of monopolies on new drugs. This bill, which is substantively similar to various Read more about Sen. Sanders Introduces Medical Innovation Prize Fund Act[…]

December 2016 Meeting on Delinkage in U.S. Senate

Posted on 3 December 201617 April 2017 by delinkageadmin

On December 2, 2016, Knowledge Ecology International hosted a technical meeting on delinkage at the United States Senate. The meeting included panels on various aspects of delinkage, including end product prizes, open source dividends, and antibiotics. Slide presentations from the meeting are available on the KEI website. A recording of the event is on YouTube.

Senator Bernie Sanders Reaffirms Support for Delinkage

Posted on 10 September 201612 September 2016 by James Love

In a policy statement on HIV AIDS and in a series of tweets, Senator Bernie Sanders reaffirmed his support of the delinkage of R&D costs from drug prices. This is from Senator Sander’s campaign 2016 statement on “Working to Create an AIDS and HIV-Free Generation.” THE PRIZE PLAN FOR HIV/AIDS As president, Bernie will Read more about Senator Bernie Sanders Reaffirms Support for Delinkage[…]